Literature DB >> 7538447

Alteration of expression in integrin beta 1-subunit correlates with invasion and metastasis in colorectal cancer.

S Fujita1, M Watanabe, T Kubota, T Teramoto, M Kitajima.   

Abstract

We have investigated the expression of the integrin beta 1 subunit in 51 colorectal cancer tissues using immunoblotting and have determined the relationship between expression and clinical stage. In comparison with normal mucosa the pre-beta-subunit (the precursor of beta 1-subunit) was increased in 15 cases and decreased in two cases, and expression of the beta 1-subunit was decreased in two cases. These alterations of expression of the beta 1-subunit were significantly correlated with lymph node metastasis and depth of invasion (P < 0.01). These results suggest that integrin plays an important role in the invasion and metastasis of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538447     DOI: 10.1016/0304-3835(95)03735-f

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

Authors:  S J Prest; R C Rees; C Murdoch; J F Marshall; P A Cooper; M Bibby; G Li; S A Ali
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Integrin expression levels correlate with invasion, metastasis and prognosis of oral squamous cell carcinoma.

Authors:  Teruhisa Ohara; Shuichi Kawashiri; Akira Tanaka; Natsuyo Noguchi; Hiroko Kitahara; Ayako Okamune; Koroku Kato; Takashi Hase; Hiromitsu Nakaya; Kunio Yoshizawa
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 3.  Tissue architecture: the ultimate regulator of epithelial function?

Authors:  C Hagios; A Lochter; M J Bissell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

4.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

Authors:  Catherine C Park; Hui Zhang; Maria Pallavicini; Joe W Gray; Frederick Baehner; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

5.  Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases.

Authors:  Sergio Lavilla-Alonso; Gerd Bauerschmitz; Usama Abo-Ramadan; Juha Halavaara; Sophie Escutenaire; Iulia Diaconu; Turgut Tatlisumak; Anna Kanerva; Akseli Hemminki; Sari Pesonen
Journal:  J Transl Med       Date:  2010-08-23       Impact factor: 5.531

6.  Prognostic value of β1 integrin expression in colorectal liver metastases.

Authors:  Nikolaos Vassos; Tilman Rau; Susanne Merkel; Fabian Feiersinger; Carol I Geppert; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

7.  NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells.

Authors:  Kazi Mokim Ahmed; Hui Zhang; Catherine C Park
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

Review 8.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

Review 9.  Molecular identification and targeting of colorectal cancer stem cells.

Authors:  Kristel Kemper; Catarina Grandela; Jan Paul Medema
Journal:  Oncotarget       Date:  2010-10

10.  Molecular targets for radiation oncology in prostate cancer.

Authors:  Tao Wang; Lucia R Languino; Jane Lian; Gary Stein; Michael Blute; Thomas J Fitzgerald
Journal:  Front Oncol       Date:  2011-07-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.